Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Sleep Country Canada: Is Decelerating Same-Store Sales Growth A Concern?

2018-07-09 seekingalpha
Sleep Country Canada is in a good position to capture market share from the liquidation of Sears Canada.
ZZZ SCC SCCAF SRSCQ SRSC

16
Giant Tiger roars across Canada as other retails competitors fade

2018-06-29 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
DLTOF SCC SRSCQ SRSC

15
Sears retirees in B.C. suffer higher pension cuts than Ontario

2018-06-25 cbc.ca
In Ontario, retirees with monthly pensions lower than $1,500 won't feel the blows of the defunct retailer's underfunded pension plan — to the tune of $270 million — or the 20-month claw back to come.
SCC SRSCQ SRSC

15
Ex-retail CEOs hail tax ruling: Old law rewarded 'form of tax evasion’

2018-06-21 cnbc
The U.S. Supreme Court's decision Thursday to allow states to force online retailers to collect local sales tax will even the playing field between e-commerce and legacy retail, industry leaders told CNBC.
XKE SCC SRSCQ SRSC

97
Sears Holdings: Buying Survival Comes At A Cost

2018-05-30 seekingalpha
Sears is contemplating various transactions that will buy it some additional time, but at the cost of dilution and selling assets.
SHLD C JPM SHLDW SCC SRSCQ SRSC

28
B. Riley Financial's (RILY) CEO Bryant Riley on Q1 2018 Results - Earnings Call Transcript

2018-05-07 seekingalpha
B. Riley Financial, Inc. (NASDAQ:RILY) Q1 2018 Results Earnings Conference Call May 7, 2018 4:30 PM ET
LLNW BONTQ BEBE RILY SCC 3772 BONT UNTD SRSCQ SRSC

15
Woolworth’s building to get a makeover

2018-04-24 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
SCC SRSCQ SRSC

18
Hudson's Bay Enters 2018 Seeking A Retail Turnaround

2018-04-05 seekingalpha
Hudson's Bay still has a huge amount of real estate value, but needs to halt the decline at some of its banners in order to be able to properly unlock that value.
SHLD HUD SHLDW SCC HBAYF SRSCQ SRSC

15
How you can have $1 million by the time you’re 40 - MarketWatch

2018-03-31 marketwatch
It can feel like hitting the $1 million mark requires having a Wall Street job, a trust fund—or decades to save. But these millionaires may change your mind.
SCC SRSCQ SRSC

15
Ontario seniors to get $750 to help with home maintenance

2018-03-28 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
SCC SRSCQ SRSC

57
Inside the Strange Odyssey of Hedge-Fund King Eddie Lampert | Vanity Fair

2018-03-26 vanityfair
Few people on Wall Street are as polarizing as Eddie Lampert, the billionaire majority shareholder of Sears and Kmart. His friends say he is reticent, while his critics find him aloof. His pals talk about his very high standards, while some observers say he is condescending, overly critical, and disengaged. Some people praise his determination and persistence, while others see only inexplicable stubbornness in sticking to failed ideas.
SHLD BGX SHLDW SCC BGLF BX SRSCQ SRSC BGB

25
H&R Real Estate Investment Trust: This 6.8% Yielding REIT Is Trading At A Significant Discount

2018-03-22 seekingalpha
The company is currently trading at a significant discount to both its peers and to its own historical average.
TGT SCC SRSCQ SRSC

28
Loblaw stumbles on Optimum-PC Points merger, bread rebate woes

2018-03-19 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
HD CDNTF LBLCF ACDVF CDNAF SCC SRSCQ SRSC AC

15
Quinsam Appoints Keith Li as CFO

2018-03-19 globenewswire
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION BY ANY UNITED STATES NEWS DISTRIBUTION SERVICE
SCC SRSCQ SRSC

18
Court Orders Inquiry into Sears Canada Dividend Payment | Chief Investment Officer

2018-03-15 ai-cio
Canada’s Ontario Superior Court of Justice has appointed Toronto-based law firm Lax O’Sullivan Lisus Gottlieb as litigation investigator to review C$3 billion ($2.34 billion) in dividends paid out to Sears Canada’s shareholders, including Sears Holdings Corp. Chief Executive Edward Lampert.
SHLD FCN SHLDW SCC SRSCQ SRSC

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...